US 12,281,312 B2
Anti-fibrinogen aptamers
Alexander Seifert, Paris (FR)
Assigned to Laboratoire Francais du Fractionnement et des Biotechnologies, Les Ulis (FR)
Filed by Laboratoire Francais du Fractionnement et des Biotechnologies, Les Ulis (FR)
Filed on Jul. 30, 2021, as Appl. No. 17/389,878.
Application 17/389,878 is a continuation of application No. 16/320,770, abandoned, previously published as PCT/EP2017/066940, filed on Jul. 6, 2017.
Claims priority of application No. 16305983 (EP), filed on Jul. 28, 2016; application No. 16305984 (EP), filed on Jul. 28, 2016; and application No. 16305985 (EP), filed on Jul. 28, 2016.
Prior Publication US 2022/0098590 A1, Mar. 31, 2022
Int. Cl. C12N 15/11 (2006.01); C12N 15/10 (2006.01); C12N 15/115 (2010.01)
CPC C12N 15/115 (2013.01) [C12N 15/1048 (2013.01); C12N 2310/16 (2013.01); C12N 2320/13 (2013.01); C12N 2330/30 (2013.01)] 9 Claims
 
1. An anti-fibrinogen aptamer that is SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3 or SEQ ID NO: 4.